PSKH2

Model summary

A soluble human signaling kinase that binds ATP and assembles with diverse protein partners to regulate phosphorylation-dependent pathways. It operates in the cytosol and concentrates at nuclear speckles, where it likely modulates RNA-processing and transcriptional hubs that govern skeletal lineage programs. By coupling cytoplasmic signaling to nuclear RNA-body dynamics, it fine-tunes phosphorylation circuits that support bone development.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The core of the protein is a bilobal kinase module: IPR011009 (Protein kinase-like domain superfamily, residues 46–351) encompasses IPR000719 (Protein kinase domain, residues 63–320), and within the N-lobe sits IPR017441 (Protein kinase, ATP binding site, residues 69–92). This ordered layout—ATP-binding site embedded in a canonical eukaryotic protein kinase fold—establishes a catalytic center that binds ATP and transfers phosphate to protein substrates. The breadth of the kinase-like superfamily signature and the explicit ATP-binding motif together cause ATP-dependent phosphotransfer chemistry and multivalent protein interactions typical of signaling kinases.

2. 02

   From this architecture, the molecular function resolves into two facets.

   First, the intact catalytic core supports protein phosphorylation chemistry, which operationally manifests as GO:0006468 at the process level and implies intrinsic catalytic activity. Second, the broad surfaces and regulatory elements of the kinase fold mediate GO:0005515 protein binding, enabling assembly with substrates and regulators. The combination of catalytic potential and scaffolding capacity is characteristic of kinases that tune developmental pathways.

3. 03

   Biological process follows directly.

   A functional kinase domain that binds ATP and modifies protein targets drives GO:0006468 protein phosphorylation. Developmental outputs are suggested by tissue-specific signaling: bone and cartilage lineages depend on kinase-controlled transcription and RNA processing. The kinase’s ability to shuttle and scaffold provides a mechanistic route to GO:0060348 bone development, where phosphorylation cascades and nuclear RNA-body dynamics coordinate osteogenic and chondrogenic programs.

4. 04

   Cellular location is inferred from both the soluble kinase architecture and the observed compartmentalization.

   The absence of transmembrane segments and the soluble fold align with GO:0005829 cytosol. The presence of nuclear speckles—ribonucleoprotein-rich hubs for pre-mRNA processing—points to GO:0016607 nuclear speck. Kinase-driven regulation of splicing and transcription frequently routes through speckles; thus, a cytosol-to-nucleus shuttling kinase that concentrates at speckles can couple cytoplasmic signaling to nuclear RNA maturation.

5. 05

   These features together suggest a mechanism: a soluble serine/threonine-like kinase that cycles between cytosol and nuclear speckles, where it phosphorylates RNA-processing and transcriptional regulators to influence osteogenic gene expression.

   It likely binds ATP via residues 69–92, stabilizes a catalytically competent active site, and uses transient protein-binding interfaces to recruit substrates. In bone development contexts, it may tune the balance between cytoplasmic signaling and nuclear RNA-body assembly.

6. 06

   Given this model, plausible interaction partners include nuclear speckle and splicing factors (e.g., SR-rich proteins and hnRNPs), transcriptional regulators of osteogenesis, and cytosolic signaling adaptors.

   These assemblies would allow the kinase to sense cytoplasmic cues and impose nuclear phosphorylation patterns that drive bone-forming programs.